Home › Funds › Two Sigma Investments › MDGL
Two Sigma Investments position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)10.47K sh
Reported value held$5.62M
Portfolio Weight0.00%
First reportedQ4 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 9.44K | $2.74M | New |
| Q1 2023 | 24.29K | $5.88M | Add |
| Q1 2026 | 800 | $418.78K | New |
| Q2 2026 | 10.47K | $5.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MDGL
- Vanguard Group 1.81M sh · $1.05B · Q4 2025
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- BlackRock Inc 1.20M sh · $644.75M · Q2 2026
- Wellington Management Group 825.71K sh · $443.37M · Q2 2026
- Citadel Advisors 688.13K sh · $369.49M · Q2 2026
- UBS Group AG 401.71K sh · $215.70M · Q2 2026
- Geode Capital Management 374.88K sh · $201.34M · Q2 2026
- Fidelity Management & Research (FMR) 356.20K sh · $191.26M · Q2 2026
- Invesco Ltd 301.44K sh · $161.86M · Q2 2026
- Goldman Sachs Group 246.28K sh · $132.24M · Q2 2026
- Norges Bank Investment Management 213.89K sh · $114.85M · Q2 2026